Serum Magnesium and Mortality in Maintenance Hemodialysis Patients

Blood Purification

Volumn 43, Issue 1-3, 2017, Pages 31-36

  Yu, Ling ^a   Li, Han ^a   Wang, Shi Xiang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cardiovascular mortality; Hemodialysis; Risk factor; Serum magnesium

Indexed keywords

C REACTIVE PROTEIN; CREATININE; LIPOPROTEIN A; PHOSPHORUS; SERUM ALBUMIN; BIOLOGICAL MARKER; MAGNESIUM;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMODIALYSIS; HUMAN; HYPERMAGNESEMIA; INFECTION; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; TIME OF DEATH; UREA NITROGEN BLOOD LEVEL; ADVERSE EFFECTS; BLOOD; CAUSE OF DEATH; FOLLOW UP; INFLAMMATION; MORTALITY; NUTRITIONAL STATUS;

BIOMARKERS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; MAGNESIUM; NUTRITIONAL STATUS; RENAL DIALYSIS;

EID: 84996656486     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000451052     Document Type: Article

References (23)

1. Liao F, Folsom AR, Brancati FL: Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 1998;136:480-490.
2. Zhang W, Iso H, Ohira T, et al. Associations of dietary magnesium intake with mortality from cardiovascular disease: the JACC study. Atherosclerosis 2012;221:587-595.
3. Larsson SC, Orsini N, Wolk A: Dietary magnesium intake and risk of stroke: a meta-analysis of prospective studies. Am J Clin Nutr 2012;95:362-366.
4. Ohira T, Peacock JM, Iso H, et al. Serum and dietary magnesium and risk of ischemic stroke: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2009;169:1437-1444.
5. Khan AM, Lubitz SA, Sullivan LM, et al. Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study. Circulation 2013;127:33-38.
6. Chiuve SE, Korngold EC, Januzzi JL Jr, et al. Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr 2011;93:253-260.
7. Turgut F, Kanbay M, Metin MR, et al. Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int Urol Nephrol 2008;40:1075-1082.
8. Kalantar-Zadeh K, Kovesdy CP, Bross R, et al. Design and development of a dialysis food frequency questionnaire. J Ren Nutr 2011;21:257-262.
9. Yu Ling, Li Han, Wang Shixiang: Correlation between serum magnesium and malnutrition-inflammation-atherosclerosis syndrome in maintenance hemodialysis patients. Chinese J Clin Nutr 2014;22:348-353.
10. Kanbay M, Yilmaz MI, Apetrii M, et al. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients. Am J Nephrol 2012;36:228-237.
11. Pakfetrat M, Malekmakan L, Roozbeh J, et al. Magnesium and its relationship to C-reactive protein among hemodialysis patients. Magnes Res 2008;21:167-170.
12. Fein P, Suda V, Borawsky C, et al. Relationship of serum magnesium to body composition and inflammation in peritoneal dialysis patients. Adv Perit Dial 2010;26:112-115.
13. Ortega O, Rodriguez I, Cobo G, et al. Lack of influence of serum magnesium levels on overall mortality and cardiovascular outcomes in patients with advanced chronic kidney disease. ISRN Nephrol 2013;2013:191786.
14. Courivaud C, Davenport A: Magnesium and the risk of all-cause and cardiac mortality in hemodialysis patients: agent provocateur or innocent bystander? Kidney Int 2014;85:17-20.
15. Liu S, Chacko S: Dietary Mg intake and biomarkers of inflammation and endothelial dysfunction; in Watson RR, Preedy VR, Zibadi S (eds): Magnesium in Human Health and Disease. New York, Humana Press, 2013, pp 35-50.
16. Nielsen FH: Magnesium, inflammation, and obesity in chronic disease. Nutr Rev 2010;68:333-340.
17. Salem S, Bruck H, Bahlmann FH, et al. Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification. Am J Nephrol 2012;35:31-39.
18. Barbagallo M, Dominguez LJ: Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys 2007;458:40-47.
19. Rochelson B, Dowling O, Schwartz N, Metz CN: Magnesium sulfate suppresses inflammatory responses by human umbilical vein endothelial cells (HuVECs) through the NFkappaB pathway. J Reprod Immunol 2007;73:101-107.
20. Ferrè S, Mazur A, Maier JA: Low-magnesium induces senescent features in cultured human endothelial cells. Magnes Res 2007;20:66-71.
21. Ferrè S, Baldoli E, Leidi M, Maier JA: Magnesium deficiency promotes a pro-atherogenic phenotype in cultured human endothelial cells via activation of NFkB. Biochim Biophys Acta 2010;1802:952-958.
22. Zernecke A, Shagdarsuren E, Weber C: Chemokines in atherosclerosis: an update. Arterioscler Thromb Vasc Biol 2008;28:1897-1908.
23. de Francisco AL, Leidig M, Covic AC, Ketteler M, Benedyk-Lorens E, Mircescu GM, Scholz C, Ponce P, Passlick-Deetjen J: Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability. Nephrol Dial Transplant 2010;25:3707-3717.